Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$8.71 - $10.72 $627 - $771
-72 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$9.2 - $23.86 $386 - $1,002
-42 Reduced 36.84%
72 $1,000
Q4 2020

Feb 03, 2021

SELL
$13.47 - $24.89 $53 - $99
-4 Reduced 3.39%
114 $3,000
Q2 2020

Aug 14, 2020

SELL
$8.86 - $15.69 $310 - $549
-35 Reduced 22.88%
118 $2,000
Q1 2020

May 14, 2020

BUY
$6.63 - $11.16 $490 - $825
74 Added 93.67%
153 $1,000
Q3 2019

Nov 14, 2019

SELL
$8.02 - $13.25 $8 - $13
-1 Reduced 1.25%
79 $1,000
Q1 2018

May 14, 2018

BUY
$13.76 - $17.12 $1,100 - $1,369
80 New
80 $1,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.